| Authors: |
Guo H; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Camargo LM; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Yeboah F; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Digan ME; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Niu H; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Pan Y; Novartis Institutes of Biomedical Research, Global Discovery Chemistry, 181 Massachusetts Avenue, Cambridge, MA, 02139, USA., Reiling S; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Soler-Llavina G; Novartis Institutes of Biomedical Research, Neuroscience, 181 Massachusetts Avenue, Cambridge, MA, 02139, USA., Weihofen WA; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Wang HR; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Shanker YG; Novartis Institutes of Biomedical Research, Neuroscience, 181 Massachusetts Avenue, Cambridge, MA, 02139, USA., Stams T; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Bill A; Novartis Institutes of Biomedical Research, Chemical Biology and Therapeutics, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA. anke.bill@novartis.com. |
